Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for October 2014

    ... of this study is to see if selinexor will improve the blood counts and bone marrow function in people with your type of MDS. ... A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS) ...

    Page last updated 09/30/2014 - 10:05am.

  2. MDS Diagnostic Spectrum

    ... scoring system for myelodysplastic syndromes . Blood. 2012:120(12):2454 WPSS Malcovati L et al. Time-dependent ... information from karyotype, platelet count and transfusion status. JCO 2011;29(4): 392. ...

    Topic section last updated 03/11/2016 - 12:23am.

  3. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ... (Procrit®) or darbepoetin (Aranesp®) work for low red blood cell counts. Romiplostin can be considered a platelet growth ... treated with romiplostin, based on prior platelet transfusion needs and blood levels of the hormone TPO. So just ...

    Interview last updated 02/07/2013 - 1:28pm.

  4. Clinical Trials Report for January 2016

    ... failure characterized by a requirement for red blood cell and platelet transfusions. Three different preparative ... is to evaluate the efficacy and safety of imetelstat in transfusion dependent participants with low or intermediate-1 risk ...

    Page last updated 01/07/2016 - 10:57am.

  5. 2013 Scholarships Awarded to Special Group of Young People

    ... Soon afterwards, doctors noticed a drop in all three blood counts and by August, Kyle was diagnosed with aplastic anemia. One month ... the friend who sat by my side for my first blood transfusion and made me a charm bracelet to commemorate the occasion; my ...

    Page last updated 06/24/2015 - 10:22am.

  6. Interviews with the Experts Managing MDS With Supportive Care and Active Treatment

    ... to giving a specific drug or agent that treats the disease. Blood transfusions are the backbone of supportive care for patients with MDS, ... If the counts improve, we keep these therapies going, with transfusion support as required especially in the initial phase of treatment. ...

    Interview last updated 09/22/2014 - 12:25pm.

  7. Immunosuppression and Stem Cell Transplantation – How Are These Treatments Chosen?

    ... who have been studied, has been useful in stimulating blood cell production. Eltrombopag is a growth factor , which was ... long term control of the disease, lessened the need for transfusion or even complete transfusion independent, and lessen the risk of ...

    Interview last updated 07/15/2015 - 10:19am.

  8. The Diagnostic Spectrum of MDS, MDS/MPN, and MF Reference Card

    ... prognostic scoring system for myelodysplastic syndromes. Blood.  2012:120(12)2454 View this article on PubMed WPSS ... information from karyotype, platelet count, and transfusion status. JCO 2011;29(4): 392. View this article on PubMed ...

    Page last updated 01/28/2015 - 10:43am.

  9. North American Pediatric Aplastic Anemia Consortium Symposium

    ... adults that causes the bone marrow to stop making blood cells.  As with all rare diseases, there is a relative lack of research ... Supportive care, which encompasses blood production transfusion and the prophylaxis and treatment of infections, is an important ...

    Page last updated 10/31/2013 - 4:06pm.

  10. Lower-Risk MDS: Diagnosis and Treatment Options

    ... or higher-risk. The first criterion is the number of low blood counts, specifically defined as hemoglobin level less than 10 ... cation–based Prognostic Scoring System (WPSS), which takes transfusion dependence into account, along with the three factors in the IPSS, ...

    Interview last updated 05/18/2012 - 1:28pm.